Rafael Holdings, Inc. (RFL) News
Track canonical SquawkNews coverage tagged to RFL, Rafael Holdings, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Rafael Holdings reports Phase 3 topline: prespecified subgroup meets significance; NDA on track
Rafael Holdings announced Phase 3 topline results for Trappsol Cyclo showing a non-significant primary result but a significant benefit in patients on background miglustat/leucine.Key Highlights:Original SEC Filing: Rafa
REGULATION | Sep 30, 2026, 11:33 AM UTC
L
Rafael Holdings, Inc. (RFL) Phase 3 Misses Primary Endpoint; Subgroup Met Significance
Rafael Holdings reported Trappsol Cyclo’s Phase 3 did not reach statistical significance on the primary endpoint, while a prespecified subgroup on miglustat and/or leucine showed a statistically significant effect. The c
NEWS | Sep 30, 2026, 11:08 AM UTC
L
Rafael Holdings Announces Topline Results From The Pivotal Phase 3 Transportnpc™ Study Of Trappsol® Cyclo™ In Niemann-Pick Disease Type C (Npc)
Rafael Holdings Inc NYSE:RFL
NEWS | Sep 30, 2026, 11:06 AM UTC